Skip to content
Open access

Sirt1 Modulates p53‑Acetylation‑Dependent Yy2‑Elf‑1‑Associated NLRP3‑Relevant Signaling in CUMS‑Evoked Aggravated Alzheimer's Disease‑Related Phenotypes.

Nov 2026 · Brain Research Bulletin · pp. 112202 · 0 citations · 61 references
Medicine

Abstract

Depressive disorder (DD) is recognized as an important comorbidity of Alzheimer's disease (AD) and is associated with aggravated cognitive impairment and neuroinflammatory responses; however, the underlying molecular mechanisms remain largely unknown. This study investigated the role of the Sirtuin 1 (Sirt1)/p53 acetylation/Yin-Yang 2 (Yy2)/E74-like ETS transcription factor 1 (Elf-1)/NLR family pyrin domain-containing 3 (NLRP3) axis in DD-associated AD phenotypes and evaluated the effects of resveratrol intervention. Bioinformatics analysis, CoIP-MS, ChIP-seq, and dual-luciferase assays were applied to identify and validate the regulatory relationships among these molecules. APP/PS1 double-transgenic mice subjected to chronic unpredictable mild stress (CUMS) and LPS-stimulated BV2 microglia were used as in vivo and in vitro models. Behavioral tests demonstrated that CUMS-induced depressive-like stress aggravated cognitive deficits and depression- and anxiety-related behavioral abnormalities in AD mice. Sirt1 expression was decreased, whereas acetylated p53 (ac-p53), Yy2, Elf-1, and NLRP3 levels were elevated in the hippocampus of DD+AD mice and activated BV2 microglia, accompanied by enhanced inflammatory and oxidative stress responses. Resveratrol treatment reduced p53 acetylation, suppressed the Yy2/Elf-1/NLRP3 pathway, alleviated inflammatory and oxidative stress responses, and improved behavioral deficits. Yy2 overexpression partially reversed the effects of resveratrol treatment. Collectively, our findings suggest that reduced Sirt1 expression promotes p53 acetylation and activates the Yy2/Elf‑1‑associated NLRP3‑relevant axis (the regulatory link between Elf‑1 and NLRP3 requires further experimental validation), contributing to neuroinflammatory responses and behavioural deficits in CUMS‑aggravated AD‑related phenotypes. Resveratrol treatment partially restored Sirt1‑related signalling and ameliorated these pathological manifestations, although further studies are required to determine its therapeutic potential and exclude Sirt1‑independent effects.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.